A Comparative Analysis of Intertransverse Nerve Block and Paravertebral Nerve Block in Endoscopic Hepatectomy
1 other identifier
interventional
80
1 country
1
Brief Summary
This study aims to compare the analgesic effect of intertransverse nerve block and paravertebral nerve block after endoscopic hepatectomy, evaluate its effectiveness and safety, and provide new ideas and clinical basis for postoperative pain management of liver surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Aug 2024
Longer than P75 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 14, 2024
August 1, 2024
2.3 years
August 12, 2024
August 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The number of effective compressions of the analgesic pump within 24 hours after surgery
Within 24 hours after the operation
Study Arms (2)
intertransverse nerve block
EXPERIMENTALTo study the analgesic effect of intertransverse nerve block after endoscopic hepatectomy
paravertebral nerve block
PLACEBO COMPARATORTo study the analgesic effect of paravertebral nerve block after endoscopic hepatectomy
Interventions
Analgesic effect of different nerve blocks
Eligibility Criteria
You may qualify if:
- years old adult, BMI\<27.9kg/m2
- : 2. American Society of Anesthesiologists ASA Grade I-III
- : 3. Patients with laparoscopic partial liver resection such as liver tumors
- : 4. Willing to participate in this study and sign the informed consent form
You may not qualify if:
- \. The patient or family member refuses to sign the informed consent form
- \. Blood coagulation dysfunction, local infection
- \. Those who have communication, communication disorders or mental abnormalities
- \. Patients with severe heart, pulmonary and renal insufficiency or patients with central system diseases
- \. For any reason, it cannot be matched with the study or the researcher believes that it is not appropriate to be included in this experiment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jie Chenlead
Study Sites (1)
The Second Affiliated Hospital Of Chongqing Medical University
Chongqing, Chongqing Municipality, 400000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- 临床教授
Study Record Dates
First Submitted
August 12, 2024
First Posted
August 14, 2024
Study Start
August 1, 2024
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 14, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share